About steroidnpeptides
The conjunction is casual. The biological ambitions bundled into it deserve more thought.
The little “n”
steroidnpeptides sounds as though it ought to have a settled opinion about getting bigger. My curiosity concerns what “bigger” might contain: bone length, lean tissue, fat, retained water or simply a change on a scale. The name puts that ambiguity on the table.
The ipamorelin experiment in ferrets exposed to cisplatin occupies an outsized space in my thinking about this name. Less weight lost was the desired direction. In the tesamorelin trials for HIV-associated lipodystrophy, reducing a particular fat depot was desirable. CJC-1295's healthy-adult work followed the hormone response. Each ambition makes sense in its own setting.
The ferret result earns its space here without a bodybuilding claim attached to it. The same applies to a trial about eating after surgery, even when the trial misses its endpoint.
Tissues and ambitions
This is a personal research-literature site about ipamorelin, CJC-1295 and tesamorelin. I distrust “growth” used to praise every desirable change, and “success” attached to every lower weight. The experiments are more interesting once those shortcuts are removed.
CJC-1295's durable chemistry deserves my admiration, as do tesamorelin's specific clinical results. With ipamorelin, my curiosity leads to appetite and gut function before the leaner-reflection promises. None of that settles a treatment decision, and these pages are not medical advice. A person's health cannot be assessed from a paper or a page.
There is no practice or shop behind this name. This site has no products, prescriptions or appointments to offer. It contains no guidance on obtaining or using anabolic steroids, and no peptide is put forward as their replacement or partner.
Reasons for caution
The weight question also has an uncomfortable side. Fluid retention, appetite changes and uncertain glucose effects complicate the attractive descriptions of these compounds. Cancer-related concerns and long-term safety deserve attention even when a short experiment looks reassuring.
My scepticism starts when a receptor explanation is followed by somebody's unverified sleep report and offered as a clinical answer. Better human outcome studies could change how much confidence is justified. Until then, there is enough here to be curious about without pretending the missing observations have already been made.
The reading list brings the source papers together. The contact page records what a useful factual correction needs.